— Know what they know.
Not Investment Advice

PALI NASDAQ

Palisade Bio, Inc.
1W: -0.7% 1M: -27.6% 3M: -29.4% YTD: -42.4% 1Y: +9.9% 3Y: -81.9% 5Y: -99.9%
$1.44
+0.01 (+0.70%)
 
Weekly Expected Move ±12.4%
$1 $1 $1 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 33 · $250.0M mcap · 167M float · 1.85% daily turnover · Short 48% of daily vol

Balance Sheet Trends

Total Assets
$134M +1134.8% ▲
5Y CAGR: +113.6%
Total Liabilities
$5M +46.5% ▲
5Y CAGR: -13.3%
Shareholders Equity
$129M +1626.9% ▲
Cash & Investments
$133M +1258.2% ▲
5Y CAGR: +183.4%
Total Debt
$71K -58.0% ▼
5Y CAGR: -45.1%
Net Debt
-$133M -1281.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$10M$12M$12M$10M$133M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$10M$12M$12M$10M$133M
Net Receivables$150K$1M$148K$24K$264K
Inventory$0$0$0$0$0
Other Current Assets$0$114K$112K$87K$572K
Total Current Assets$12M$15M$13M$10M$134M
Property, Plant & Equip.$112K$310K$208K$87K$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$26K$0$26K$55K
Other Non-Current Assets$894K$694K$516K$273K$68K
Total Non-Current Assets$1M$1M$724K$386K$123K
Total Assets$13M$16M$14M$11M$134M
— Liabilities —
Accounts Payable$2M$2M$698K$1M$767K
Short-Term Debt$87K$88K$158K$79K$71K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$511K$574K$831K$0$4M
Total Current Liabilities$2M$3M$3M$3M$5M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$3M$61K$63K$152K$328K
Total Non-Current Liabilities$3M$272K$153K$152K$328K
Total Liabilities$5M$3M$3M$3M$5M
— Equity —
Common Stock$3K$30K$93K$27K$2M
Retained Earnings-$95M-$109M-$122M-$136M-$153M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$7M$12M$11M$7M$129M
Total Liabilities & Equity$13M$16M$14M$11M$134M
— Key Metrics —
Total Debt$199K$404K$369K$169K$71K
Net Debt-$10M-$12M-$12M-$10M-$133M
Total Investments$0$26K$0$26K$55K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms